TD Cowen Starts NervGen Pharma Corp (NGEN) at Buy, 'A New Generation In Spinal Cord Injury Treatment Is Here' Jun 11, 2026 05:32AM
NervGen prices $60 million public offering at $2.50 per share May 21, 2026 11:27PM
NervGen Announces Pricing of US$60.0 Million Public Offering of Securities May 21, 2026 11:27PM
NervGen announces public offering of shares and warrants May 21, 2026 04:01PM
NervGen Announces Proposed Public Offering of Securities May 21, 2026 04:01PM


Feb 18, 2026 07:30AM NervGen Pharma to Participate at Upcoming Investor Conferences